全关节置换器械10年召回风险研究
研究查询美国FDA 510(k)数据库2008年1月1日至2018年12月31日批准的904个髋和膝关节置换器械,发现94个(19.4%)髋器械和85个(20.3%)膝器械被召回,10年召回风险约24%,髋膝之间无统计学差异;最常见召回原因为过程控制和器械设计,分别占29.6%和26.3%。
要点
- 904个关节置换器械中,髋485个(53.7%)、膝419个(46.3%)。
- 94个(19.4%)髋器械和85个(20.3%)膝器械被召回。
- 髋和膝关节置换器械10年召回风险约24%,两者无统计学差异。
核心结论
- 关节置换器械的召回风险高于既往认识。
- 需要改进上市后监管策略并增加医生参与发现和报告器械安全问题,以加强患者安全。
研究设计与样本
- 查询美国FDA 510(k)数据库,纳入2008年1月1日至2018年12月31日批准的骨科器械,并按产品代码归类为髋和膝关节置换器械。
- 研究期间数据库共纳入904个关节置换器械,其中髋关节器械485个(53.7%),膝关节器械419个(46.3%)。
- 记录召回数量、日期和原因,采用累积发生率函数比较髋和膝关节置换器械的召回风险。
主要发现
- 94个(19.4%)髋关节器械和85个(20.3%)膝关节器械被召回。
- 髋和膝关节置换器械10年召回风险约24%,两者之间无统计学差异。
- 最常见召回原因为过程控制和器械设计,分别占29.6%和26.3%,研究组间无显著差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Orthopaedic devices comprise nearly 20% of devices on the market and 12% to 20% of these devices undergo a recall within 10 years. More than 95% of these devices are approved without supporting clinical data through the Food and Drug Administration's 510(k) pathway. The risk of recall of orthopaedic arthroplasty devices approved through the 510(k) pathway has not been previously studied. METHODS: The FDA 510(k) database was queried for orthopaedic devices approved between January 01, 2008 and December 31, 2018 and subsequently codified to hip and knee arthroplasty devices using product codes. The database included 904 arthroplasty devices during the study period, with hip and knee making up 53.7% (485) and 46.3% (419) of devices, respectively. Information regarding numbers, dates, and reasons for recall were recorded. Cumulative incidence function was conducted to compare the risk of recall between hip and knee arthroplasty. RESULTS: In total, 94 (19.4%) hip and 85 (20.3%) knee devices were recalled. The hazard of recall by 10 years for hip and knee arthroplasty devices was approximately 24%, with no statistical differences between each region. The most common causes of recall were process control and device design, accounting for 29.6% and 26.3% of recalls, respectively, with no significant difference between study groups. CONCLUSION: The risk of recall for arthroplasty devices is more than that previously understood. Improved postmarket surveillance strategies along with increased physician participation in detecting and reporting device safety issues are necessary to strengthen patient safety.
引用
- DeRuyter MT, Mansy LN, Krumme JW, et al. Risk of Recall for Total Joint Arthroplasty Devices Over 10 Years. J Arthroplasty. 2023. PMID: 36773660. doi:10.1016/j.arth.2023.01.068
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。